Interleukin-6 trans signalling enhances photodynamic therapy by modulating cell cycling

Photodynamic therapy (PDT) of solid tumours causes tissue damage that elicits local and systemic inflammation with major involvement of interleukin-6 (IL-6). We have previously reported that PDT-treated cells lose responsiveness to IL-6 cytokines. Therefore, it is unclear whether PDT surviving tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, L-H, Baumann, H, Tracy, E, Wang, Y, Hutson, A, Rose-John, S, Henderson, B W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360250/
https://www.ncbi.nlm.nih.gov/pubmed/17987036
http://dx.doi.org/10.1038/sj.bjc.6604073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360250/
https://www.ncbi.nlm.nih.gov/pubmed/17987036
http://dx.doi.org/10.1038/sj.bjc.6604073

Ejemplares similares